Rhythm Biosciences Director’s Initial Shareholdings

Rhythm Biosciences Ltd. (AU:RHY) has released an update.

Rhythm Biosciences Limited has disclosed the initial director’s interest notice for newly appointed Director David Atkins, effective from September 30, 2024. The notice reveals Atkins holds 4 million unlisted ordinary fully paid shares, along with options for an additional 4 million shares expiring in 2026 and 2028. No interests in securities where Atkins is not the registered holder or interests in contracts were reported.

For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.